| Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 51 (6), 786-792, 2016 | 562 | 2016 |
| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ... The Lancet Haematology 7 (10), e737-e745, 2020 | 555 | 2020 |
| Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ... Bone marrow transplantation 50 (8), 1037-1056, 2015 | 464 | 2015 |
| Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ... Bone marrow transplantation 52 (6), 811-817, 2017 | 417 | 2017 |
| Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019 RF Duarte, M Labopin, P Bader, GW Basak, C Bonini, C Chabannon, ... Bone marrow transplantation 54 (10), 1525-1552, 2019 | 329 | 2019 |
| Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry D Farge, J Passweg, JM Van Laar, Z Marjanovic, C Besenthal, J Finke, ... Annals of the Rheumatic Diseases 63 (8), 974-981, 2004 | 314 | 2004 |
| Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 50 (4), 476-482, 2015 | 291 | 2015 |
| Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, GW Basak, ... Bone marrow transplantation 49 (7), 865-872, 2014 | 232 | 2014 |
| Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation JR Passweg, H Baldomero, C Peters, HB Gaspar, S Cesaro, P Dreger, ... Bone marrow transplantation 49 (6), 744-750, 2014 | 231 | 2014 |
| Structural and functional features of the CD34 antigen: an update F Lanza, L Healy, DR Sutherland Journal of biological regulators and homeostatic agents 15 (1), 1-13, 2001 | 221 | 2001 |
| Proposed definition of ‘poor mobilizer’in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo A Olivieri, M Marchetti, R Lemoli, C Tarella, A Iacone, F Lanza, ... Bone marrow transplantation 47 (3), 342-351, 2012 | 220 | 2012 |
| GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia A Venditti, A Piciocchi, A Candoni, L Melillo, V Calafiore, R Cairoli, ... Blood, The Journal of the American Society of Hematology 134 (12), 935-945, 2019 | 170 | 2019 |
| MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia A Tafuri, C Gregorj, MT Petrucci, MR Ricciardi, M Mancini, G Cimino, ... Blood, The Journal of the American Society of Hematology 100 (3), 974-981, 2002 | 151 | 2002 |
| A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs D Campioni, R Rizzo, M Stignani, L Melchiorri, L Ferrari, S Moretti, ... Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2009 | 131 | 2009 |
| Darbepoetin alpha for the treatment of anaemia in low‐intermediate risk myelodysplastic syndromes P Musto, F Lanza, E Balleari, A Grossi, A Falcone, G Sanpaolo, ... British journal of haematology 128 (2), 204-209, 2005 | 131 | 2005 |
| CD34-positive cells: biology and clinical relevance CC Stella, M Cazzola, P De Fabritiis, A De Vincentiis, AM Gianni, F Lanza, ... Haematologica 80 (4), 367-387, 1995 | 123 | 1995 |
| Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from … A Bazarbachi, G Bug, F Baron, E Brissot, F Ciceri, I Abou Dalle, H Döhner, ... haematologica 105 (6), 1507, 2020 | 120 | 2020 |
| Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients A Spyridonidis, M Labopin, BN Savani, R Niittyvuopio, D Blaise, ... Bone marrow transplantation 55 (6), 1114-1125, 2020 | 112 | 2020 |
| Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes D Campioni, P Secchiero, F Corallini, E Melloni, S Capitani, F Lanza, ... The American journal of pathology 166 (2), 557-563, 2005 | 108 | 2005 |
| A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells R Rizzo, D Campioni, M Stignani, L Melchiorri, GP Bagnara, L Bonsi, ... Cytotherapy 10 (4), 364-375, 2008 | 105 | 2008 |
